Marshall Wace
CLDI.WS

Marshall Wace’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History

Marshall Wace’s Portfolio CLDI.WS Stock Details CLDI.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-70,000
Closed -$16.1K – 3080
2024
Q1 		$16.1K Sell
70,000
-2,278
-3% -$137 ﹤0.01% 2373
2023
Q4 		$109K Sell
72,278
-14,309
-17% -$1.62K ﹤0.01% 2037
2023
Q3 		$288K Hold
86,587
– – ﹤0.01% 1900
2023
Q2 		$908K Hold
86,587
– – ﹤0.01% 1755
2023
Q1 		$889K Sell
86,587
-403,411
-82% -$31.3K ﹤0.01% 1872
2022
Q4 		$4.98M Hold
489,998
– – 0.01% 1190
2022
Q3 		$4.83M Hold
489,998
– – 0.01% 1395
2022
Q2 		$4.87M Hold
489,998
– – 0.01% 1360
2022
Q1 		$4.85M Hold
489,998
– – 0.01% 1397
2021
Q4 		$4.82M Buy
+489,998
New +$276K 0.01% 1383

Other funds holding CLDI.WS

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
AI
Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
EAM
Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return